{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:03:01Z","timestamp":1790694181284,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100031253","name":"\u0130n\u00f6n\u00fc \u00dcniversitesi","doi-asserted-by":"publisher","award":["TOA-2020-2347"],"award-info":[{"award-number":["TOA-2020-2347"]}],"id":[{"id":"10.13039\/100031253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31048-4","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:44:41Z","timestamp":1768373081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RETRACTED ARTICLE: Evaluation of the cardiopulmonary effects of repurposed COVID-19 therapeutics in healthy rats"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9018-7849","authenticated-orcid":false,"given":"Onural","family":"Ozhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-7867","authenticated-orcid":false,"given":"Azibe","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7793-1119","authenticated-orcid":false,"given":"Busra","family":"Bakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4447-6233","authenticated-orcid":false,"given":"Ahmet","family":"Ulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7956-9272","authenticated-orcid":false,"given":"Zeynep","family":"Kucukakcali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1723-2556","authenticated-orcid":false,"given":"Elif","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-1696","authenticated-orcid":false,"given":"Nigar","family":"Vardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6080-229X","authenticated-orcid":false,"given":"Burhan","family":"Ates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-3468","authenticated-orcid":false,"given":"Hakan","family":"Parlakpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"31048_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.gendis.2020.06.004","volume":"7","author":"AH Al-Rohaimi","year":"2020","unstructured":"Al-Rohaimi, A. H., Al Otaibi, F. & Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic. Genes Dis. 7, 491\u2013501. https:\/\/doi.org\/10.1016\/j.gendis.2020.06.004 (2020).","journal-title":"Genes Dis."},{"key":"31048_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable Bat origin. Nature 579, 270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7 (2020).","journal-title":"Nature"},{"key":"31048_CR3","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.mayocp.2020.04.027","volume":"95","author":"P Vijayvargiya","year":"2020","unstructured":"Vijayvargiya, P. et al. Treatment considerations for COVID-19: A critical review of the evidence (or lack Thereof). Mayo Clin. Proc. 95, 1454\u20131466. https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.027 (2020).","journal-title":"Mayo Clin. Proc."},{"key":"31048_CR4","doi-asserted-by":"publisher","unstructured":"Tian, L. et al. Molnupiravir and Its Antiviral Activity Against COVID-19. Front. Immunol. 13, https:\/\/doi.org\/10.3389\/fimmu.2022.855496 (2022).","DOI":"10.3389\/fimmu.2022.855496"},{"key":"31048_CR5","doi-asserted-by":"publisher","unstructured":"Korula, P. et al. Favipiravir for treating COVID-19. The Cochrane database of systematic reviews 2, Cd015219, (2024). https:\/\/doi.org\/10.1002\/14651858.CD015219.pub2","DOI":"10.1002\/14651858.CD015219.pub2"},{"key":"31048_CR6","doi-asserted-by":"publisher","unstructured":"Seydi, E., Hassani, M. K., Naderpour, S., Arjmand, A. & Pourahmad, J. Cardiotoxicity of chloroquine and hydroxychloroquine through mitochondrial pathway. BMC Pharmacol. Toxicol. 24, https:\/\/doi.org\/10.1186\/s40360-023-00666-x (2023).","DOI":"10.1186\/s40360-023-00666-x"},{"key":"31048_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1799785","volume":"19","author":"M Infante","year":"2021","unstructured":"Infante, M., Ricordi, C., Alejandro, R., Caprio, M. & Fabbri, A. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Expert Rev. anti-infective Therapy. 19, 5\u201316. https:\/\/doi.org\/10.1080\/14787210.2020.1799785 (2021).","journal-title":"Expert Rev. anti-infective Therapy"},{"key":"31048_CR8","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","volume":"75","author":"D Zhou","year":"2020","unstructured":"Zhou, D., Dai, S. M. & Tong, Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J. Antimicrob. Chemother. 75, 1667\u20131670. https:\/\/doi.org\/10.1093\/jac\/dkaa114 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"31048_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","volume":"71","author":"X Yao","year":"2020","unstructured":"Yao, X. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin. Infect. Diseases: Official Publication Infect. Dis. Soc. Am. 71, 732\u2013739. https:\/\/doi.org\/10.1093\/cid\/ciaa237 (2020).","journal-title":"Clin. Infect. Diseases: Official Publication Infect. Dis. Soc. Am."},{"key":"31048_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Y Furuta","year":"2017","unstructured":"Furuta, Y., Komeno, T. & Nakamura, T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc. Jpn. Acad. B. 93, 449\u2013463. https:\/\/doi.org\/10.2183\/pjab.93.027 (2017).","journal-title":"Proc. Jpn. Acad. B"},{"key":"31048_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","volume":"102","author":"S Joshi","year":"2021","unstructured":"Joshi, S. et al. Role of favipiravir in the treatment of COVID-19. Int. J. Infect. Dis. 102, 501\u2013508. https:\/\/doi.org\/10.1016\/j.ijid.2020.10.069 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"31048_CR12","doi-asserted-by":"publisher","first-page":"115292","DOI":"10.1016\/j.ejmech.2023.115292","volume":"252","author":"MS Bekheit","year":"2023","unstructured":"Bekheit, M. S., Panda, S. S. & Girgis, A. S. Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2. Eur. J. Med. Chem. 252, 115292. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115292 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"31048_CR13","doi-asserted-by":"publisher","unstructured":"Fischer, W. A. et al. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Science translational medicine 14, eabl7430, (2022). https:\/\/doi.org\/10.1126\/scitranslmed.abl7430","DOI":"10.1126\/scitranslmed.abl7430"},{"key":"31048_CR14","doi-asserted-by":"publisher","first-page":"111887","DOI":"10.1016\/j.fct.2020.111887","volume":"147","author":"S Thakur","year":"2021","unstructured":"Thakur, S. et al. Exploring the magic bullets to identify achilles\u2019 heel in SARS-CoV-2: delving deeper into the sea of possible therapeutic options in Covid-19 disease: an update. Food Chem. Toxicology.\u00a0147, 111887. https:\/\/doi.org\/10.1016\/j.fct.2020.111887 (2021).","journal-title":"Food Chem. Toxicology: Int. J. Published Br. Industrial Biol. Res. Association"},{"key":"31048_CR15","doi-asserted-by":"publisher","first-page":"106101","DOI":"10.1016\/j.ijantimicag.2020.106101","volume":"56","author":"MS Khuroo","year":"2020","unstructured":"Khuroo, M. S. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal. Int. J. Antimicrob. Agents. 56, 106101. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106101 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"31048_CR16","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s40121-021-00500-z","volume":"10","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Potential adverse effects of dexamethasone therapy on COVID-19 patients: review and recommendations. Infect. Dis. Therapy. 10, 1907\u20131931. https:\/\/doi.org\/10.1007\/s40121-021-00500-z (2021).","journal-title":"Infect. Dis. Therapy"},{"key":"31048_CR17","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s42399-020-00610-8","volume":"2","author":"MH Ahmed","year":"2020","unstructured":"Ahmed, M. H. & Hassan, A. Dexamethasone for the treatment of coronavirus disease (COVID-19): a review. SN Compr. Clin. Med. 2, 2637\u20132646. https:\/\/doi.org\/10.1007\/s42399-020-00610-8 (2020).","journal-title":"SN Compr. Clin. Med."},{"key":"31048_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby, P. et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436 (2021).","journal-title":"N. Engl. J. Med."},{"key":"31048_CR19","doi-asserted-by":"crossref","unstructured":"\u00c7olak, C. & Parlakp\u0131nar, H. Hayvan deneyleri: in vivo denemelerin bildirimi: ARRIVE K\u0131lavuzu-Derleme. J. Turgut Ozal Med. Cent. 19, 128\u2013131 https:\/\/doi.org\/10.7247\/jiumf.19.2.14 (2012).","DOI":"10.7247\/jiumf.19.2.14"},{"key":"31048_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. basic. Clin. Pharm. 7, 27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703 (2016).","journal-title":"J. basic. Clin. Pharm."},{"key":"31048_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/fcp.12599","volume":"35","author":"O Ozhan","year":"2021","unstructured":"Ozhan, O., Parlakpinar, H. & Acet, A. Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats. Fundam. Clin. Pharmacol. 35, 669\u2013680. https:\/\/doi.org\/10.1111\/fcp.12599 (2021).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"31048_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11419-025-00720-9","volume":"43","author":"O Ozhan","year":"2025","unstructured":"Ozhan, O. et al. Acute and subacute cardiovascular effects of synthetic cannabinoid JWH-018 in rat. Forensic Toxicol. 43, 266\u2013279. https:\/\/doi.org\/10.1007\/s11419-025-00720-9 (2025).","journal-title":"Forensic Toxicol."},{"key":"31048_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/cvr\/22.7.447","volume":"22","author":"MJ Walker","year":"1988","unstructured":"Walker, M. J. et al. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovascular. Res. 22, 447\u2013455. https:\/\/doi.org\/10.1093\/cvr\/22.7.447 (1988).","journal-title":"Cardiovascular. Res."},{"key":"31048_CR24","doi-asserted-by":"crossref","unstructured":"Yildiz, A. et al. Effects of drugs commonly used in Sars-CoV-2 infection on renal tissue in rats. Ann. Med. Res. 30, 1209-1216. https:\/\/doi.org\/10.5455\/annalsmedres.2023.08.180 (2023).","DOI":"10.5455\/annalsmedres.2023.08.180"},{"key":"31048_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3 (1976).","journal-title":"Anal. Biochem."},{"key":"31048_CR26","doi-asserted-by":"publisher","unstructured":"Li, Z., Paulin, D., Lacolley, P., Coletti, D. & Agbulut, O. Vimentin as a target for the treatment of COVID-19. BMJ open. respiratory Res. 7, https:\/\/doi.org\/10.1136\/bmjresp-2020-000623 (2020).","DOI":"10.1136\/bmjresp-2020-000623"},{"key":"31048_CR27","doi-asserted-by":"publisher","unstructured":"Li, Z. et al. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases. mBio. 12, e0254221, (2021). https:\/\/doi.org\/10.1128\/mBio.02542-21","DOI":"10.1128\/mBio.02542-21"},{"key":"31048_CR28","doi-asserted-by":"publisher","first-page":"29256","DOI":"10.1038\/s41598-024-72192-7","volume":"14","author":"E Yilmaz","year":"2024","unstructured":"Yilmaz, E., Yilmaz, D. & Cacan, E. Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin. Sci. Rep. 14, 29256. https:\/\/doi.org\/10.1038\/s41598-024-72192-7 (2024).","journal-title":"Sci. Rep."},{"key":"31048_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1165\/rcmb.2022-0039LE","volume":"67","author":"K Ruskowski","year":"2022","unstructured":"Ruskowski, K. et al. Persistently elevated plasma concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in patients with COVID-19 in the intensive care unit. Am. J. Respir. Cell Mol. Biol. 67, 405\u2013408. https:\/\/doi.org\/10.1165\/rcmb.2022-0039LE (2022).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"31048_CR30","doi-asserted-by":"publisher","first-page":"101497","DOI":"10.1016\/j.genrep.2022.101497","volume":"26","author":"S Karabulut Uzuncakmak","year":"2022","unstructured":"Karabulut Uzuncakmak, S., Dirican, E., Naldan, M. E., Kesmez Can, F. & Hal\u0131c\u0131, Z. Investigation of CYP2E1 and Caspase-3 gene expressions in COVID-19 patients. Gene Rep. 26, 101497. https:\/\/doi.org\/10.1016\/j.genrep.2022.101497 (2022).","journal-title":"Gene Rep."},{"key":"31048_CR31","doi-asserted-by":"publisher","first-page":"100234","DOI":"10.1016\/j.xagr.2023.100234","volume":"3","author":"MA Bachnas","year":"2023","unstructured":"Bachnas, M. A. et al. Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and TNF-alpha expression. AJOG Global Rep. 3, 100234. https:\/\/doi.org\/10.1016\/j.xagr.2023.100234 (2023).","journal-title":"AJOG Global Rep."},{"key":"31048_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.22088\/cjim.13.0.264","volume":"13","author":"M Ramezani","year":"2022","unstructured":"Ramezani, M. et al. Altered serum and cerebrospinal fluid TNF-\u03b1, caspase 3, and IL 1\u03b2 in COVID-19 disease. Caspian J. Intern. Med. 13, 264\u2013269. https:\/\/doi.org\/10.22088\/cjim.13.0.264 (2022).","journal-title":"Caspian J. Intern. Med."},{"key":"31048_CR33","doi-asserted-by":"publisher","unstructured":"Yin, J. X. et al. Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis. Infect. Dis. poverty. 12, https:\/\/doi.org\/10.1186\/s40249-023-01086-z (2023).","DOI":"10.1186\/s40249-023-01086-z"},{"key":"31048_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/jir.2022.0185","volume":"43","author":"M Ghofrani Nezhad","year":"2023","unstructured":"Ghofrani Nezhad, M., Jami, G., Kooshkaki, O., Chamani, S. & Naghizadeh, A. The role of inflammatory cytokines (Interleukin-1 and Interleukin-6) as a potential biomarker in the different stages of COVID-19 (Mild, Severe, and Critical). J. Int. Soc. Interferon Cytokine Res. 43, 147\u2013163. https:\/\/doi.org\/10.1089\/jir.2022.0185 (2023).","journal-title":"J. Interferon Cytokine Research: Official J. Int. Soc. Interferon Cytokine Res."},{"key":"31048_CR35","doi-asserted-by":"publisher","unstructured":"Mohd Zawawi, Z. et al. Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-\u03b1) in COVID-19: Prognosis, Therapeutic and Management. Int. J. Mol. Sci. 24, https:\/\/doi.org\/10.3390\/ijms24076142 (2023).","DOI":"10.3390\/ijms24076142"},{"key":"31048_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-022-01803-2","volume":"83","author":"A Plocque","year":"2023","unstructured":"Plocque, A. et al. Should we interfere with the Interleukin-6 receptor during COVID-19: what do we know so far? Drugs. 83, 1\u201336. https:\/\/doi.org\/10.1007\/s40265-022-01803-2 (2023).","journal-title":"Drugs"},{"key":"31048_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10875-020-00899-z","volume":"41","author":"W Udomsinprasert","year":"2021","unstructured":"Udomsinprasert, W., Jittikoon, J., Sangroongruangsri, S. & Chaikledkaew, U. Circulating levels of Interleukin-6 and Interleukin-10, but not tumor necrosis Factor-Alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with Meta-analysis. J. Clin. Immunol. 41, 11\u201322. https:\/\/doi.org\/10.1007\/s10875-020-00899-z (2021).","journal-title":"J. Clin. Immunol."},{"key":"31048_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.7150\/ijbs.51811","volume":"17","author":"PT Goud","year":"2021","unstructured":"Goud, P. T., Bai, D. & Abu-Soud, H. M. A Multiple-Hit hypothesis involving reactive oxygen species and myeloperoxidase explains clinical deterioration and fatality in COVID-19. Int. J. Biol. Sci. 17, 62\u201372. https:\/\/doi.org\/10.7150\/ijbs.51811 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"31048_CR39","doi-asserted-by":"publisher","unstructured":"Esmaeili-Nadimi, A. et al. Total Antioxidant Capacity and Total Oxidant Status and Disease Severity in a Cohort Study of COVID-19 Patients. Clin. Lab. 69, https:\/\/doi.org\/10.7754\/Clin.Lab.2022.220416 (2023).","DOI":"10.7754\/Clin.Lab.2022.220416"},{"key":"31048_CR40","doi-asserted-by":"publisher","first-page":"100897","DOI":"10.1016\/j.nmni.2021.100897","volume":"42","author":"B Karkhanei","year":"2021","unstructured":"Karkhanei, B., Talebi Ghane, E. & Mehri, F. Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19. New Microbes New Infections. 42, 100897. https:\/\/doi.org\/10.1016\/j.nmni.2021.100897 (2021).","journal-title":"New. Microbes new. Infections"},{"key":"31048_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.59556\/japi.72.0575","volume":"72","author":"M Jindal","year":"2024","unstructured":"Jindal, M., Lehl, S. S., Jaswal, S., Bhardwaj, N. & Gupta, M. Total antioxidant status and oxidative stress in patients with COVID-19 infection. J. Assoc. Phys. India. 72, 36\u201339. https:\/\/doi.org\/10.59556\/japi.72.0575 (2024).","journal-title":"J. Assoc. Phys. India"},{"key":"31048_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/2045-9912.385414","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang, H., Zhang, C., Hua, W. & Chen, J. Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia. Med. Gas Res. 14, 39\u201347. https:\/\/doi.org\/10.4103\/2045-9912.385414 (2024).","journal-title":"Med. Gas Res."},{"key":"31048_CR43","doi-asserted-by":"publisher","first-page":"1277552","DOI":"10.3389\/fmicb.2023.1277552","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Inhaled nitric oxide: can it serve as a savior for COVID-19 and related respiratory and cardiovascular diseases? Front. Microbiol. 14, 1277552. https:\/\/doi.org\/10.3389\/fmicb.2023.1277552 (2023).","journal-title":"Front. Microbiol."},{"key":"31048_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.amjms.2022.04.015","volume":"364","author":"VP Jani","year":"2022","unstructured":"Jani, V. P., Munoz, C. J., Govender, K., Williams, A. T. & Cabrales, P. Implications of microvascular dysfunction and nitric oxide mediated inflammation in severe COVID-19 infection. Am. J. Med. Sci. 364, 251\u2013256. https:\/\/doi.org\/10.1016\/j.amjms.2022.04.015 (2022).","journal-title":"Am. J. Med. Sci."},{"key":"31048_CR45","doi-asserted-by":"publisher","first-page":"e23852","DOI":"10.7759\/cureus.23852","volume":"14","author":"A Ghosh","year":"2022","unstructured":"Ghosh, A., Joseph, B. & Anil, S. Nitric oxide in the management of respiratory consequences in COVID-19: A scoping review of a different treatment approach. Cureus 14, e23852. https:\/\/doi.org\/10.7759\/cureus.23852 (2022).","journal-title":"Cureus"},{"key":"31048_CR46","doi-asserted-by":"publisher","first-page":"014001","DOI":"10.1088\/1752-7163\/abc302","volume":"15","author":"FLM Ricciardolo","year":"2020","unstructured":"Ricciardolo, F. L. M., Bertolini, F., Carriero, V. & H\u00f6gman, M. Nitric oxide\u2019s physiologic effects and potential as a therapeutic agent against COVID-19. J. Breath Res. 15, 014001. https:\/\/doi.org\/10.1088\/1752-7163\/abc302 (2020).","journal-title":"J. Breath Res."},{"key":"31048_CR47","doi-asserted-by":"publisher","first-page":"e23536","DOI":"10.1002\/jbt.23536","volume":"38","author":"E Erba\u015f","year":"2024","unstructured":"Erba\u015f, E., Celep, N. A., Tekiner, D., Gen\u00e7, A. & Gedikli, S. Assessment of toxicological effects of favipiravir (T-705) on the lung tissue of rats: an experimental study. J. Biochem. Mol. Toxicol. 38, e23536. https:\/\/doi.org\/10.1002\/jbt.23536 (2024).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"31048_CR48","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-023-06649-6","volume":"623","author":"T Sanderson","year":"2023","unstructured":"Sanderson, T. et al. A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes. Nature 623, 594\u2013600. https:\/\/doi.org\/10.1038\/s41586-023-06649-6 (2023).","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1038\/s41598-026-71685-x","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31048-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:47:59Z","timestamp":1790693279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31048-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31048"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31048-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-71685-x","URL":"https:\/\/doi.org\/10.1038\/s41598-026-71685-x","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An application was made to Inonu University Faculty of Medicine Animal Experiments Local Ethics Committee for ethical approval and ethics committee permission was obtained at the meeting dated 06.01.2022 with ethical approval number 2021\/1\u20136.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1770"}}